EGFR and breast cancer: Additionally, our prognostic analysis of genes encoding proteins in the EGFR/PI3K/AKT signalling pathway and GPX4 in breast cancer revealed that reduced activation of the EGFR/PI3K/AKT pathway and decreased GPX4 expression were associated with better patient outcomes (Supplementary Figure 2F).